SYSTM Wealth Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,876
Closed -$360K 479
2024
Q2
$360K Sell
12,876
-63,508
-83% -$1.75M 0.08% 159
2024
Q1
$2.12M Sell
76,384
-115,320
-60% -$3.2M 0.27% 111
2023
Q4
$5.52M Buy
191,704
+3,058
+2% +$92.4K 0.76% 25
2023
Q3
$6.26M Sell
188,646
-35,773
-16% -$1.27M 0.96% 14
2023
Q2
$8.23M Buy
224,419
+17,059
+8% +$664K 1.11% 10
2023
Q1
$8.46M Sell
207,360
-11,674
-5% -$504K 1.3% 12
2022
Q4
$11.2M Buy
+219,034
New +$10.5M 1.4% 5

Other funds holding PFE

SYSTM Wealth Solutions's PFE Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Pfizer (PFE) in Q3 2024, closing a stake of 12,876 shares — an estimated $360K sold.

SYSTM Wealth Solutions first reported a position in PFE in Q4 2022 and held it in 7 quarters. The position peaked at $11.2M in Q4 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 12,876 Pfizer shares in Q3 2024, an estimated $360K.
  • SYSTM Wealth Solutions first reported a position in Pfizer in Q4 2022 and held it in 7 quarters.
  • SYSTM Wealth Solutions's Pfizer position peaked at $11.2M in Q4 2022.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.